Gilead Sciences to Present at Upcoming Investor Conferences

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

Evercore ISI Annual HealthCONx Conference on Tuesday, November 29 at 1:00 PM Eastern Time

Piper Sandler Healthcare Conference on Wednesday, November 30 at 11:30 AM Eastern Time

Nasdaq Investor Conference on Wednesday, December 7 at 1:00 PM Greenwich Mean Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005033/en/

Jacquie Ross, Investors
[email protected]

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
• Global Times: What does China’s 4.7 percent growth in the first half of 2026 mean?
• LUX Announces First Anniversary Under Creative Capital Ownership With Exclusive Gianan Wine Collaboration